Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
27.80
Ask:
29.80
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Statement re Related Party Transaction

24 Jul 2015 15:12

RNS Number : 0682U
Maven Income and Growth VCT 5 PLC
24 July 2015
 



Maven Income and Growth VCT 5 PLC (the "Company")

 

Statement re Related Party Transaction

 

The Company is managed by Maven Capital Partners UK LLP ("Maven").

 

The Company has agreed with Maven that the base fee rate of the annual management fee payable to Maven under the investment management agreement will increase from 1.5% to 1.6% of total assets of the Company (exclusive of VAT) with effect from 1 June 2015. This increase in the base fee has been agreed by the Company in order to compensate Maven for additional fixed costs that it has committed to pay on behalf of the Company. As Maven is a related party of the Company under the Listing Rules, the increase in the fee payable by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

Pursuant to an offer agreement dated 20 October 2014 between the Company and Maven in relation to an offer for subscription launched by the Company pursuant to a joint prospectus dated 20 October 2014, the Company agreed to the payment to Maven of a fee of an amount equal to 2.5% of the amounts remitted to the Company with an investor's application (including any amounts requested to be facilitated) in respect of applications accepted under that offer less (i) an amount equal to any early investment incentive discounts being made available by the Company (as set out in the prospectus) in respect of applications accepted under that offer, and (ii) any amounts that Maven agreed to waive in respect of applications accepted under that offer. As Maven was a related party of the Company under the Listing Rules at the time, the payment of such fee by the Company to Maven was a transaction to which Listing Rule 11.1.10R applied.

Further, William Nixon and his spouse agreed, in relation to the offer referred to above and prior to the close of that offer, to subscribe for up to £60,000 of shares in the Company. As associates of Maven, William Nixon and his spouse were related parties of the Company under the Listing Rules and consequently the subscriptions were transactions to which Listing Rule 11.1.10R applied.

The fees paid to Maven under the offer agreement and the subscriptions for shares of William Nixon and his spouse in the Company (as referred to above) have been taken into account in determining the application of the related party rules of the Listing Rules to the increase in the base fee rate of the annual management fee referred to above.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRZZLFLEDFFBBB
Date   Source Headline
20th May 202610:20 amRNSAdmission of Further Securities to Trading
15th May 202610:10 amRNSIssue of Equity - Dividend Investment Scheme
12th May 20263:39 pmRNSUnaudited NAV - Dividend Investment Scheme
8th May 20264:10 pmRNSTransaction in Own Shares
28th Apr 20263:55 pmRNSResult of AGM
28th Apr 20261:35 pmRNSResult of AGM
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:30 amRNSAdmission of Further Securities to Trading
14th Apr 202611:11 amRNSIssue of Equity
8th Apr 20269:35 amRNSAdmission of Further Securities to Trading
27th Mar 20265:07 pmRNSOffer for Subscription - Fully Subscribed
25th Mar 202610:59 amRNSAdmission of Further Securities to Trading
25th Mar 20267:00 amRNSAnnual Financial Report
24th Mar 202612:13 pmRNSIssue of Equity
17th Mar 20264:36 pmRNSUnaudited Net Asset Value
3rd Mar 20264:31 pmRNSTransaction in Own Shares - correction
27th Feb 20265:04 pmRNSTransaction in Own Shares
26th Feb 20264:53 pmRNSTransaction in Own Shares
26th Feb 20269:15 amRNSDividend Declaration
18th Feb 20265:01 pmRNSAdmission of Further Securities to Trading
17th Feb 202611:11 amRNSDirector/PDMR Shareholding
17th Feb 202610:58 amRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
21st Jan 202611:13 amRNSAdmission of Further Securities to Trading
16th Jan 20269:47 amRNSIssue of Equity
14th Jan 20262:44 pmRNSUnaudited NAV - Dividend Investment Scheme
16th Dec 202511:15 amRNSDirector/PDMR Shareholding
16th Dec 202510:30 amRNSIssue of Equity
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20253:45 pmRNSResult of General Meeting
7th Oct 20254:15 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:11 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:17 pmRNSStatement re Dividend Investment Scheme
17th Jul 20253:21 pmRNSHalf-year Report
16th Jul 20255:33 pmRNSTransaction in Own Shares
16th Jul 20257:08 amRNSStatement re Offer for Subscription
10th Jul 20254:50 pmRNSStatement re Unaudited NAV and Interim Dividend
14th May 20254:46 pmRNSTransaction in Own Shares
9th May 20259:59 amRNSIssue of Equity
6th May 202511:55 amRNSIssue of Equity
2nd May 20251:27 pmRNSUnaudited NAV - Dividend Investment Scheme
29th Apr 20253:20 pmRNSResult of AGM
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
15th Apr 20259:32 amRNSDirector/PDMR Shareholding
4th Apr 20256:22 pmRNSIssue of Equity
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:14 pmRNSDirector/PDMR Shareholding
27th Mar 20251:09 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.